Back
Medpace Holdings Vs. Cellectar Biosciences Industry Stock Comparison
Sell
31
MEDP
Medpace Holdings
Last Price:
326.20
Seasonality Move:
16.85%
Sell
35
CLRB
Cellectar Biosciences
Last Price:
1.93
Seasonality Move:
-16.37%
Sell
31
Medpace Holdings (MEDP)
is a Sell
Is Medpace Holdings a Buy, Sell or Hold?
- The current Medpace Holdings [MEDP] share price is $320.58. The Score for MEDP is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- MEDP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy, Sell or Hold?
- The current Cellectar Biosciences [CLRB] share price is $1.92. The Score for CLRB is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- CLRB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MEDP Stock Price Chart
What is Medpace Holdings's stock price today?
-
The Medpace Holdings share price today is $320.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MEDP is experiencing selling pressure, which indicates risk of future bearish movement.
CLRB Stock Price Chart
What is Cellectar Biosciences's stock price today?
-
The Cellectar Biosciences share price today is $1.92
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing selling pressure, which indicates risk of future bearish movement.
MEDP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -7.33 | Sell |
Relative Strength Index (14 RSI): | 31.84 | Sell |
Chaikin Money Flow: | -1126953 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (339.03 - 378.39) | Sell |
Bollinger Bands (100): | (363.29 - 413.55) | Sell |
CLRB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 33.01 | Sell |
Chaikin Money Flow: | -158239 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.05 - 2.17) | Sell |
Bollinger Bands (100): | (2.05 - 3.03) | Sell |
MEDP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 355.7 | Sell |
20-day SMA: | 351.33 | Sell |
50-day SMA: | 373.78 | Sell |
200-day SMA: | 371.2 | Sell |
8-day EMA: | 349.87 | Sell |
20-day EMA: | 355.91 | Sell |
50-day EMA: | 369.88 | Sell |
200-day EMA: | 360.07 | Sell |
CLRB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.05 | Sell |
20-day SMA: | 2.1 | Sell |
50-day SMA: | 2.14 | Sell |
200-day SMA: | 2.98 | Sell |
8-day EMA: | 2.03 | Sell |
20-day EMA: | 2.08 | Sell |
50-day EMA: | 2.21 | Sell |
200-day EMA: | 2.64 | Sell |
Medpace Holdings Earnings Growth & MEDP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.68 per share, an increase next quarter of $0.42 per share, an increase this year of $2.69 per share, and an increase next year of $1.35 per share.
Cellectar Biosciences Earnings Growth & CLRB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.02 per share, an increase this year of $1.08 per share, and an increase next year of $1.21 per share.
Medpace Holdings Technical Analysis
Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cellectar Biosciences Technical Analysis
Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |